Literature DB >> 1375809

Alpha-fetoprotein levels in normal adults.

D Ball1, E Rose, E Alpert.   

Abstract

Alpha-fetoprotein (AFP) is a fetal specific glycoprotein normally produced primarily by the fetal liver. Normally, AFP levels decline rapidly after birth, reaching undetectable levels (less than 10 ng/ml) within several months after birth. The authors have developed a more sensitive radioimmunoassay, which has allowed them to study low levels of AFP in normal adults and to determine factors which may affect its normal level. Two hundred and seventy normal Houston blood donors were screened for the absence of hepatitis B and normal ALT levels. The mean AFP level was 3.04 ng/ml +/- 1.9 SD. There was a statistically significant higher level in men compared to women (p less than .004). Regression analysis demonstrated a statistically significant increase of AFP levels with age both in men (p less than .05) and in women (p less than .01). These data delineate the normal level of serum AFP in normal adults in the United States. With the normal level now defined, it becomes possible to compare levels in different populations including those exposed to hepatotoxins or hepatocarcinogens in the environment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375809     DOI: 10.1097/00000441-199203000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  18 in total

1.  A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis.

Authors:  L C Pollard; J Murray; M Moody; E J Stewart; E H S Choy
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

Review 2.  A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.

Authors:  A S Khazali; A M Clark; A Wells
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

3.  A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.

Authors:  S Yuce; Oz Sahin; R Bedir; T Ayaz; T Durakoglugil
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

4.  α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectors.

Authors:  Liqun Zhang; Maria P Limberis; Catherine Thompson; Marcelo B Antunes; Cindy Luongo; James M Wilson; Peter L Collins; Raymond J Pickles
Journal:  Hum Gene Ther       Date:  2010-11-03       Impact factor: 5.695

5.  Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.

Authors:  Gautam Mondal; Urmimala Chatterjee; Yogesh K Chawla; Bishnu Pada Chatterjee
Journal:  Glycoconj J       Date:  2010-12-14       Impact factor: 2.916

6.  Candidate serum biomarkers for early intestinal cancer using 15N metabolic labeling and quantitative proteomics in the ApcMin/+ mouse.

Authors:  Melanie M Ivancic; Edward L Huttlin; Xiaodi Chen; Jennifer K Pleiman; Amy A Irving; Adrian D Hegeman; William F Dove; Michael R Sussman
Journal:  J Proteome Res       Date:  2013-08-08       Impact factor: 4.466

7.  Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis.

Authors:  Myron John Tong; Thatcher Thi Huynh; Surachate Siripongsakun; Patrick Weijen Chang; Lori Terese Tong; Yen Phi Ha; Edward Alphonso Mena; Matthew Frank Weissman
Journal:  Hepatol Int       Date:  2015-07-30       Impact factor: 6.047

8.  Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.

Authors:  John B Kisiel; Brian A Dukek; Reddappa V S R Kanipakam; Hassan M Ghoz; Tracy C Yab; Calise K Berger; William R Taylor; Patrick H Foote; Nasra H Giama; Kristeen Onyirioha; Mohamed A Abdallah; Kelli N Burger; Seth W Slettedahl; Douglas W Mahoney; Thomas C Smyrk; Jason T Lewis; Maria Giakoumopoulos; Hatim T Allawi; Graham P Lidgard; Lewis R Roberts; David A Ahlquist
Journal:  Hepatology       Date:  2019-02-05       Impact factor: 17.425

9.  Direct acting antiviral-induced dynamic reduction of serum α fetoprotein in hepatitis C patients without hepatocellular carcinoma.

Authors:  Tung Huynh; Ke-Qin Hu
Journal:  Front Med       Date:  2019-10-26       Impact factor: 4.592

10.  The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance.

Authors:  Sarah-Louise Kelly; Thomas G Bird
Journal:  J Immunobiol       Date:  2016-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.